Cancer Research UK logo.
SearchDonate
  • Search

A study of atezolizumab for people with triple negative breast cancer that has spread

Overview

Cancer types:

Breast cancer, Secondary cancers

Status:

Results

Phase:

Phase 3

Details

This study was for people whose cancer had spread locally and surgery wasn’t possible or it had spread elsewhere and who hadn’t had treatment.

Triple negative breast cancers are cancers that don’t have for oestrogen, progesterone or Her2.

Recruitment start: 1 June 2015

Recruitment end: 4 May 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Peter Schmid

Supported by

Roche

Experimental Cancer Medicine Centre (ECMC)

Last reviewed: 20 May 2019

CRUK internal database number: 13835

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.